What does the Innovation Core do?

Oct 21, 2024 | Conduits News, Edition 5

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a commercially viable product, or to recognize the potential for commercialization.

i3 Prism

  • i3 Prism is an early-stage technology commercialization fund focused on women and Black, Indigenous and People of Color (BIPOC) innovators at Mount Sinai who aim to bring new health care solutions to patients and society, and advance technologies to the next level from a commercial perspective. Selected applicants will receive up to $33K in funding, which will be distributed based on the achievement of milestones.

i3 Genesis

  • i3 Genesis is the inaugural funding opportunity for early-stage healthcare technologies at Mount Sinai with clear potential for commercialization. This program aims to support and translate innovations by providing funding to achieve value inflection points.

i3 Accelerator

  • i3 Accelerator advances the development of discoveries from Mount Sinai into groundbreaking technologies that aim to help the patient population. The goal is to increase the pace of commercialization for a promising technology by applying a strategic and milestone-driven investment. Researchers collaborate with MSIP to execute a project strategy to advance technologies beyond the lab bench.

Elementa Labs

  • Elementa Labs is a virtual incubator program powered by MSIP that helps position healthcare and biotechnology startup companies for the next stage in their development. The program allows these entities to explore ways to strategically align their efforts with Mount Sinai and gain access to subject matter expertise in healthcare and science, allowing for a better understanding of their customers and the potential advancement of their core technology platforms.

Entrepreneurship Bootcamp

  • The MSIP Entrepreneurship Bootcamp educates participants in the fundamentals of health care technology commercialization at Mount Sinai. The 12-week program is open to all members of the Mount Sinai community who are interested in learning how to develop a healthcare solution and build a commercial path that aims to impact the patient population. Participants who fully complete the Bootcamp (including modules and assignments) will pre-qualify for the subsequent Tech Launchpad.

Innovation Sprint

  • The MSIP Innovation Sprint is an abridged version of the Entrepreneurship Bootcamp to rapidly bring participants up to speed on the fundamentals of commercialization and entrepreneurship. Sprint participants already have a health care solution they are developing that is beyond the concept stage.

Tech Launchpad

  • Upon successful completion of the Entrepreneurship Bootcamp or the Innovation Sprint, participants will apply the knowledge gained to help further develop their technologies and position their solutions to gain traction through partnerships, investment, or other commercial paths.

Mount Sinai Pitch Challenge

  • The Mount Sinai Pitch Challenge is the Entrepreneurship Program’s capstone event, where finalists will compete for a cash prize and pro-bono services to continue the development of a health care solution. Teams will be judged by members of the venture capital community and seasoned entrepreneurs or operators.

MSIP Fellows Program

  • The MSIP Fellows Program is designed to educate and engage early-career scientists, attorneys, and/or business professionals who have strong interests in the commercialization process of new therapeutics, diagnostics, medical devices or digital health technologies to the worldwide patient population. If successfully completed, the fellow will be prepared to leverage their expertise in science, business and law to help drive research discoveries to the marketplace. The two-phase scheme will train participants in the various aspects of technology commercialization

Mount Sinai Ideas Network

  • The Mount Sinai Ideas Network is a virtual experience that features Mount Sinai’s wide range of healthcare technologies and innovative products that aim to benefit patient lives. Through collaborating with various departments and teams, the Ideas Network was developed to serve as a gateway to the Health System’s innovation ecosystem for new and existing students, faculty, commercialization partners, donors, and more.

 

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

Recent ConduITS News

What is the Innovation Core?

Mount Sinai’s Innovation Partners (MSIP) is the technology commercialization arm of the Mount Sinai Health System, responsible for driving the real-world application of Mount Sinai discoveries and inventions, and the development of research partnerships with industry....

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more